Literature DB >> 1280419

Molecular cloning of the human brain and gastric cholecystokinin receptor: structure, functional expression and chromosomal localization.

J R Pisegna1, A de Weerth, K Huppi, S A Wank.   

Abstract

The receptors for the brain and gastrointestinal peptide, cholecystokinin, can be classified into CCKA and CCKB subtypes. Having recently cloned the rat CCKB receptor, we used it's cDNA to isolate the human CCKB receptor homologue from brain and stomach which encodes a 447 amino acid protein with 90% identity to both rat CCKB and canine gastrin receptors. Northern hybridization identifies transcripts from stomach, pancreas, brain and gallbladder. The CCKB receptor gene maps to chromosome 11. Expression of the receptor cDNA in COS-7 cells was characteristic of a CCKB receptor subtype pharmacology. These data confirm that we have cloned a novel gene for the human brain and stomach CCKB receptor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280419      PMCID: PMC6719700          DOI: 10.1016/0006-291x(92)91557-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  29 in total

1.  Brain and gastrointestinal cholecystokinin receptor family: structure and functional expression.

Authors:  S A Wank; J R Pisegna; A de Weerth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Pharmacological characterization of type B cholecystokinin binding sites on the human JURKAT T lymphocyte cell line.

Authors:  M F Lignon; N Bernad; J Martinez
Journal:  Mol Pharmacol       Date:  1991-05       Impact factor: 4.436

3.  Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.

Authors:  C W Lin; B R Bianchi; T R Miller; D G Witte; C A Wolfram
Journal:  Am J Physiol       Date:  1992-06

4.  Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases.

Authors:  P J Kennelly; E G Krebs
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

5.  CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.

Authors:  J Staley; R T Jensen; T W Moody
Journal:  Peptides       Date:  1990 Sep-Oct       Impact factor: 3.750

6.  PD134308, a selective antagonist of cholecystokinin type B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes.

Authors:  Z Wiesenfeld-Hallin; X J Xu; J Hughes; D C Horwell; T Hökfelt
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

Review 7.  Cholecystokinin-dopamine interactions.

Authors:  J N Crawley
Journal:  Trends Pharmacol Sci       Date:  1991-06       Impact factor: 14.819

8.  CCK-B (gastrin) receptor regulates gastric histamine release and acid secretion.

Authors:  A K Sandvik; H L Waldum
Journal:  Am J Physiol       Date:  1991-06

9.  Expression cloning and characterization of the canine parietal cell gastrin receptor.

Authors:  A S Kopin; Y M Lee; E W McBride; L J Miller; M Lu; H Y Lin; L F Kolakowski; M Beinborn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

10.  Evidence for an involvement of the brain cholecystokinin B receptor in anxiety.

Authors:  L Singh; A S Lewis; M J Field; J Hughes; G N Woodruff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

View more
  38 in total

1.  Intestinal transit of fat depends on accelerating effect of cholecystokinin and slowing effect of an opioid pathway.

Authors:  Henry C Lin; Oren Zaidel; Susan Hum
Journal:  Dig Dis Sci       Date:  2002-10       Impact factor: 3.199

2.  A single nucleotide polymorphism of the cholecystokinin-B receptor predicts risk for pancreatic cancer.

Authors:  Jill P Smith; John F Harms; Gail L Matters; Christopher O McGovern; Francesca M Ruggiero; Jiangang Liao; Kristin K Fino; Emily E Ortega; Evan L Gilius; John A Phillips
Journal:  Cancer Biol Ther       Date:  2012-02-01       Impact factor: 4.742

3.  Thermodynamic analysis of ligands at cholecystokinin CCK2 receptors in rat cerebral cortex.

Authors:  E A Harper; S P Roberts; S B Kalindjian
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

4.  Expression of gastrin, gastrin/CCK-B and gastrin/CCK-C receptors in human colorectal carcinomas.

Authors:  A Imdahl; T Mantamadiotis; S Eggstein; E H Farthmann; G S Baldwin
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

5.  Analysis of variation in L-365,260 competition curves in radioligand binding assays.

Authors:  E A Harper; S P Roberts; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

6.  Analysis of the variation in the action of L-365,260 at CCKB/gastrin receptors in rat, guinea-pig and mouse isolated gastric tissue assays.

Authors:  S P Roberts; E A Harper; G F Watt; V P Gerskowitch; R A Hull; N P Shankley; J W Black
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

Review 7.  Cholecystokinin receptors.

Authors:  P Boden; M D Hall; J Hughes
Journal:  Cell Mol Neurobiol       Date:  1995-10       Impact factor: 5.046

Review 8.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

9.  Localization of the murine cholecystokinin A and B receptor genes.

Authors:  L C Samuelson; M S Isakoff; K A Lacourse
Journal:  Mamm Genome       Date:  1995-04       Impact factor: 2.957

10.  Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine.

Authors:  L Singh; R J Oles; M J Field; P Atwal; G N Woodruff; J C Hunter
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.